Who owns ADAGIO THERAPEUTICS INC?
- Ticker: IVVD
- CUSIP Number: 00534a102
Tip: Access positions for across all investors
Analyze quarterly positions in Adagio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adagio Therapeutics stock
Who bought or sold ADAGIO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Mithril II GP | 11M | $6.8M | 0% | Mar 2025 |
|
| Maverick Capital | 11M | $6.6M | -7% | Mar 2025 |
|
| Deep Track Capital | 9.7M | $5.9M | -9% | Mar 2025 |
|
| M28 Capital Management | 9.2M | $4.1M | 0% | Dec 2024 |
|
| BlackRock | 5.3M | $3.2M | 13% | Mar 2025 |
|
| Vanguard Group | 4.4M | $2.7M | 1% | Mar 2025 |
|
| 683 Capital Management | 3.0M | $1.3M | 0% | Dec 2024 |
|
| Redmile Group | 2.3M | $1.4M | -24% | Mar 2025 |
|
| FMR | 2.1M | $1.2M | -64% | Mar 2025 |
|
| Bain Capital Life Sciences Investors | 1.8M | $797k | 0% | Dec 2024 |
|
| Geode Capital Management | 1.6M | $984k | 2% | Mar 2025 |
|
| State Street Corporation | 997k | $604k | -13% | Mar 2025 |
|
| OrbiMed Advisors | 934k | $565k | -19% | Mar 2025 |
|
| Deutsche Bank Aktiengesellschaft | 655k | $400k | -25% | Mar 2025 |
|
| Northern Trust | 589k | $357k | 5% | Mar 2025 |
|
| Duquesne Family Office | 571k | $253k | 0% | Dec 2024 |
|
| UBS Group | 441k | $267k | 14% | Mar 2025 |
|
| AQR Capital Management | 411k | $259k | 2051% | Mar 2025 |
|
| Tang Capital Management | 400k | $242k | 21% | Mar 2025 |
|
| Citadel Advisors | 287k | $174k | 303% | Mar 2025 |
|
| Goldman Sachs Group | 256k | $155k | 2% | Mar 2025 |
|
| Two Sigma Investments | 241k | $146k | -34% | Mar 2025 |
|
| Morgan Stanley | 201k | $89k | 100% | Dec 2024 |
|
| GSA Capital Partners | 193k | $117k | -58% | Mar 2025 |
|
| Charles Schwab Investment Management | 187k | $113k | 0% | Mar 2025 |
|
| Bank of New York Mellon | 161k | $98k | 0% | Mar 2025 |
|
| Barclays | 113k | $68k | -11% | Mar 2025 |
|
| XTX Topco | 109k | $66k | 100% | Mar 2025 |
|
| Invesco | 109k | $66k | 191% | Mar 2025 |
|
| Nuveen | 107k | $65k | 100% | Mar 2025 |
|
| Nuveen Asset Management | 107k | $48k | 0% | Dec 2024 |
|
| United Capital Financial Advisers | 97k | $59k | 100% | Mar 2025 |
|
| a16z Perennial Management | 80k | $48k | 0% | Mar 2025 |
|
| Rhumbline Advisers | 79k | $48k | -17% | Mar 2025 |
|
| SG Americas Securities | 79k | $48k | 60% | Mar 2025 |
|
| Intech Investment Management | 71k | $43k | 100% | Mar 2025 |
|
| Bank of America Corporation | 66k | $29k | -27% | Dec 2024 |
|
| Acadian Asset Management | 65k | $39k | -87% | Mar 2025 |
|
| Citigroup | 58k | $35k | -6% | Mar 2025 |
|
| Mirae Asset Global Etfs Holdings | 48k | $29k | 4% | Mar 2025 |
|
| Wells Fargo & Company | 48k | $29k | 2% | Mar 2025 |
|
| Susquehanna International | 45k | $20k | 97% | Dec 2024 |
|
| HPM Partners | 39k | $24k | 100% | Mar 2025 |
|
| Corebridge Financial | 39k | $24k | -1% | Mar 2025 |
|
| Jpmorgan Chase & Co | 38k | $23k | -85% | Mar 2025 |
|
| CWM | 34k | $20k | 3964% | Mar 2025 |
|
| Qube Research & Technologies | 32k | $14k | -81% | Dec 2024 |
|
| Proficio Capital Partners | 27k | $12k | 0% | Dec 2024 |
|
| Savant Capital Management | 26k | $16k | 100% | Mar 2025 |
|
| T. Rowe Price Associates | 26k | $12k | 0% | Dec 2024 |
|
| Miller Financial Services | 22k | $13k | 100% | Mar 2025 |
|
| Tower Research Capital | 20k | $8.8k | 127% | Dec 2024 |
|
| Dynamic Technology Lab Private | 18k | $11k | 100% | Mar 2025 |
|
| Dimensional Fund Advisors | 17k | $7.7k | 0% | Dec 2024 |
|
| ProShare Advisors | 17k | $10k | -23% | Mar 2025 |
|
| Manufacturers Life Insurance Company | 16k | $9.7k | 100% | Mar 2025 |
|
| Neuberger Berman Group | 16k | $9.7k | -26% | Mar 2025 |
|
| Beacon Pointe Advisors | 15k | $6.6k | -44% | Dec 2024 |
|
| Abel Hall | 10k | $6.1k | 100% | Mar 2025 |
|
| Naples Global Advisors | 10k | $6.1k | 0% | Mar 2025 |
|
| Summit Investment Advisors | 7.8k | $4.7k | 0% | Mar 2025 |
|
| Legal & General Group | 6.9k | $4.2k | 0% | Mar 2025 |
|
| Bnp Paribas Arbitrage, Snc | 6.6k | $4.0k | -82% | Mar 2025 |
|
| Royal Bank of Canada | 6.6k | $4.3k | -42% | Mar 2025 |
|
| California State Teachers Retirement System | 5.7k | $2.5k | 0% | Dec 2024 |
|
| New York State Common Retirement Fund | 4.0k | $2.0k | 0% | Mar 2025 |
|
| Group One Trading | 3.7k | $1.6k | 100% | Dec 2024 |
|
| Amalgamated Bank | 2.7k | $2.0k | 0% | Mar 2025 |
|
| SBI Securities | 1.6k | $938.960000 | 8% | Mar 2025 |
|
| Sterling Capital Management | 1.4k | $828.050400 | -49% | Mar 2025 |
|
| EverSource Wealth Advisors | 622.00 | $375.999000 | 776% | Mar 2025 |
|
| NISA Investment Advisors | 500.00 | $303.000000 | -67% | Mar 2025 |
|
| Parallel Advisors | 496.00 | $299.980800 | 0% | Mar 2025 |
|
| Coldstream Capital Management | 245.00 | $149.009000 | 100% | Mar 2025 |
|
| True Wealth Design | 52.00 | $32.000800 | 100% | Mar 2025 |
|
| Advisor Group Holdings | 17.00 | $9.999400 | -99% | Mar 2025 |
|
| IFP Advisors | 7.00 | $3.999800 | 0% | Mar 2025 |
|
| Pnc Financial Services | 7.00 | $3.000200 | 100% | Dec 2024 |
|
| Farther Finance Advisors | 1.00 | $1.000000 | 0% | Mar 2025 |
|
Who sold out of Adagio Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Slate Path Capital | Sep 2024 | 3.7M | $3.8M |
| Two Sigma Advisers | Dec 2024 | 304k | $135k |
| Bridgeway Capital Management | Dec 2024 | 303k | $134k |
| Renaissance Technologies | Dec 2024 | 167k | $74k |
| Marshall Wace | Sep 2024 | 120k | $123k |
| Jane Street | Dec 2024 | 117k | $52k |
| Millennium Management | Dec 2024 | 38k | $17k |
| Virtu Financial | Dec 2024 | 31k | $14k |
| Sandia Investment Management | Dec 2024 | 27k | $12k |
| Graham Capital Management | Sep 2024 | 24k | $24k |
| Ing Investment Management | Sep 2024 | 11k | $11k |
| JustInvest | Sep 2024 | 11k | $11k |
| Picton Mahoney Asset Management | Dec 2024 | 4.7k | $2.0k |
| Simplex Trading | Dec 2024 | 4.4k | $1.0k |
| New Wave Wealth Advisors | Dec 2024 | 300.00 | $132.990000 |